CRISPR/Cas12a Collateral Cleavage Activity for Sensitive 3'-5' Exonuclease Assay

Jae Hoon Jeung1,2, Hyogu Han1,3, Chang Yeol Lee4

  • 1Material & Component Convergence R&D Department, Korea Institute of Industrial Technology (KITECH), Ansan 15588, Republic of Korea.

Biosensors
|November 24, 2023
PubMed
Summary

This study introduces a CRISPR/Cas12a method for detecting 3'-5' exonuclease (Exo III) activity. The technique offers sensitive detection and can screen for Exo III inhibitors, aiding in disease research.